Activation of the complement system by nanoparticles and strategies for complement inhibition

被引:1
作者
Haroon, Hajira B. [1 ,2 ]
Dhillon, Elisha [1 ]
Farhangrazi, Z. Shadi [3 ,4 ]
Trohopoulos, Panagiotis N. [5 ]
Simberg, Dmitri [6 ,7 ]
Moghimi, S. Moein [1 ,2 ,7 ]
机构
[1] Newcastle Univ, Sch Pharm, Newcastle Upon Tyne NE1 7RU, England
[2] Newcastle Univ, Translat & Clin Res Inst, Fac Hlth & Med Sci, Newcastle Upon Tyne NE2 4HH, England
[3] SM Discovery Grp Inc, Denver, CO USA
[4] SM Discovery Grp Ltd, Durham, England
[5] CosmoPHOS Ltd, Thessaloniki, Greece
[6] Univ Colorado, Anschutz Med Ctr, Skaggs Sch Pharm, Dept Pharmaceut Sci,Translat Bionanosci Lab, Aurora, CO USA
[7] Univ Colorado, Colorado Ctr Nanomed & Nanosafety, Anschutz Med Ctr, Aurora, CO USA
关键词
Complement; Complement inhibitors; Complement regulators; Complement receptors; Complosome; Nanoparticles; Opsonisation; C3; PATHWAY; BINDING; COMPONENT; RESPONSES; ANAPHYLATOXIN; ANTIBODIES; PROTEINS; SURFACES;
D O I
10.1016/j.ejpb.2023.11.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The complement system is a multicomponent and multifunctional arm of the innate immune system. Complement contributes to non-specific host defence and maintains homeostasis through multifaceted processes and pathways, including crosstalk with the adaptive immune system, the contact (coagulation) and the kinin systems, and alarmin high-mobility group box 1. Complement is also present intracellularly, orchestrating a wide range of housekeeping and physiological processes in both immune and nonimmune cells, thus showing its more so-phisticated roles beyond innate immunity, but its roles are still controversial. Particulate drug carriers and nanopharmaceuticals typically present architectures and surface patterns that trigger complement system in different ways, resulting in both beneficial and adverse responses depending on the extent of complement activation and regulation as well as pathophysiological circumstances. Here we consider the role of complement system and complement regulations in host defence and evaluate the mechanisms by which nanoparticles trigger and modulate complement responses. Effective strategies for the prevention of nanoparticle-mediated complement activation are introduced and discussed.
引用
收藏
页码:227 / 240
页数:14
相关论文
共 95 条
  • [51] Cancer nanomedicine and the complement system activation paradigm: Anaphylaxis and tumour growth
    Moghimi, S. M.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2014, 190 : 556 - 562
  • [52] Perspectives on complement and phagocytic cell responses to nanoparticles: From fundamentals to adverse reactions
    Moghimi, S. Moein
    Haroon, Hajira B.
    Yaghmur, Anan
    Hunter, A. Christy
    Papini, Emanuele
    Farhangrazi, Z. Shadi
    Simberg, Dmitri
    Trohopoulos, Panagiotis N.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2023, 356 : 115 - 129
  • [53] Nanometer- and angstrom-scale characteristics that modulate complement responses to nanoparticles
    Moghimi, S. Moein
    Haroon, Hajira B.
    Yaghmur, Anan
    Simberg, Dmitri
    Trohopoulos, Panagiotis N.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2022, 351 : 432 - 443
  • [54] Critical issues and pitfalls in serum and plasma handling for complement analysis in nanomedicine and bionanotechnology
    Moghimi, S. Moein
    Simberg, Dmitri
    [J]. NANO TODAY, 2022, 44
  • [55] Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production
    Moghimi, S. Moein
    Hamad, Islam
    Andresen, Thomas L.
    Jorgensen, Kent
    Szebeni, Janos
    [J]. FASEB JOURNAL, 2006, 20 (14) : 2591 - +
  • [56] Complement activation by drug carriers and particulate pharmaceuticals: Principles, challenges and opportunities
    Moghimi, S. Moein
    Simberg, Dmitri
    Papini, Emanuele
    Farhangrazi, Z. Shadi
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2020, 157 : 83 - 95
  • [57] Pro-inflammatory concerns with lipid nanoparticles
    Moghimi, Seyed Moein
    Simberg, Dmitri
    [J]. MOLECULAR THERAPY, 2022, 30 (06) : 2109 - 2110
  • [58] Hijacking Factor H for Complement Immune Evasion
    Moore, Sara R.
    Menon, Smrithi S.
    Cortes, Claudio
    Ferreira, Viviana P.
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [59] The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
    Ndeupen, Sonia
    Qin, Zhen
    Jacobsen, Sonya
    Bouteau, Aurelie
    Estanbouli, Henri
    Igyarto, Botond Z.
    [J]. ISCIENCE, 2021, 24 (12)
  • [60] The tumour microenvironment links complement system dysregulation and hypoxic signalling
    Olcina, Monica M.
    Kim, Ryan K.
    Melemenidis, Stavros
    Graves, Edward E.
    Giaccia, Amato J.
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2018, 92 (1093)